Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Accenture
Express Scripts
Colorcon
Daiichi Sankyo
Harvard Business School
Fish and Richardson
UBS
McKinsey

Generated: June 21, 2018

DrugPatentWatch Database Preview

KAYEXALATE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Kayexalate patents expire, and when can generic versions of Kayexalate launch?

Kayexalate is a drug marketed by Concordia Pharms Inc and is included in one NDA.

The generic ingredient in KAYEXALATE is sodium polystyrene sulfonate. There are one thousand four hundred and twenty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.
Summary for KAYEXALATE
Drug patent expirations by year for KAYEXALATE

US Patents and Regulatory Information for KAYEXALATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Concordia Pharms Inc KAYEXALATE sodium polystyrene sulfonate POWDER;ORAL, RECTAL 011287-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Dow
Moodys
Daiichi Sankyo
Covington
QuintilesIMS
Fuji
McKinsey
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.